Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Andrology

Free Subscription Articles published in Prostate Retrieve available abstracts of 64 articles: HTML format

Single Articles

July 2021
1. JIN R, Strand DW, Forbes CM, Case T, et al
   The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
   Prostate. 2021 Jul 20. doi: 10.1002/pros.24190.
   PubMed     Abstract available
   
   
   
2. BASSILY D, Wong V, Phillips JL, Fraiman M, et al
   Rezum for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia.
   Prostate. 2021 Jul 20. doi: 10.1002/pros.24201.
   PubMed     Abstract available
   
   
   April 2021
3. QIAN S, Zhang S, Xia W, Xu D, et al
   Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross-sectional study.
   Prostate. 2021 Apr 16. doi: 10.1002/pros.24128.
   PubMed     Abstract available
   
   
   January 2021
4. LIU Y, Zhang Y, Zhang M, Meng J, et al
   Activated autophagy restored the impaired frequency and function of regulatory T cells in chronic prostatitis.
   Prostate. 2021;81:29-40.
   PubMed     Abstract available
   
   
   December 2020
5. ZHANG LG, Yu ZQ, Yang C, Chen J, et al
   Effect of Eriocalyxin B on prostatic inflammation and pelvic pain in a mouse model of experimental autoimmune prostatitis.
   Prostate. 2020;80:1394-1404.
   PubMed     Abstract available
   
   
   
6. MIZOGUCHI S, Mori K, Shin T, Wang Z, et al
   Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor beta.
   Prostate. 2020;80:1413-1420.
   PubMed     Abstract available
   
   
   November 2020
7. JAIN S, Samal AG, Das B, Pradhan B, et al
   Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells.
   Prostate. 2020;80:1341-1352.
   PubMed     Abstract available
   
   
   
8. GAT Y, Joshua S, Vuk-Pavlovic S, Goren M, et al
   Paying the price for standing tall: Fluid mechanics of prostate pathology.
   Prostate. 2020;80:1297-1303.
   PubMed     Abstract available
   
   
   October 2020
9. WANG K, Pascal LE, Li F, Chen W, et al
   Tight junction protein claudin-1 is downregulated by TGF-beta1 via MEK signaling in benign prostatic epithelial cells.
   Prostate. 2020;80:1203-1215.
   PubMed     Abstract available
   
   
   
10. CHEN W, Pascal LE, Wang K, Dhir R, et al
    Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
    Prostate. 2020;80:1177-1187.
    PubMed     Abstract available
    
    
    September 2020
11. EPSTEIN DJ, Thompson LDR, Saleem A, Kao CS, et al
    Fungal prostatitis due to endemic mycoses and Cryptococcus: A multicenter case series.
    Prostate. 2020;80:1006-1011.
    PubMed     Abstract available
    
    
    
12. PENG X, Guo H, Chen J, Wang J, et al
    The effect of pirfenidone on rat chronic prostatitis/chronic pelvic pain syndrome and its mechanisms.
    Prostate. 2020;80:917-925.
    PubMed     Abstract available
    
    
    
13. SMITH DK, Hasanali SL, Wang J, Kallifatidis G, et al
    Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
    Prostate. 2020;80:938-949.
    PubMed     Abstract available
    
    
    August 2020
14. LAMAS CA, Kido LA, Hermes TA, Nogueira-Lima E, et al
    Brazilian berry extract (Myrciaria jaboticaba): A promising therapy to minimize prostatic inflammation and oxidative stress.
    Prostate. 2020;80:859-871.
    PubMed     Abstract available
    
    
    June 2020
15. DU HX, Liu Y, Zhang LG, Zhan CS, et al
    Abnormal gut microbiota composition is associated with experimental autoimmune prostatitis-induced depressive-like behaviors in mice.
    Prostate. 2020;80:663-673.
    PubMed     Abstract available
    
    
    May 2020
16. POPOVICS P, Awadallah WN, Kohrt SE, Case TC, et al
    Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Prostate. 2020 May 1. doi: 10.1002/pros.23986.
    PubMed     Abstract available
    
    
    
17. WU Y, Jiang H, Tan M, Lu X, et al
    Screening for chronic prostatitis pathogens using high-throughput next-generation sequencing.
    Prostate. 2020;80:577-587.
    PubMed     Abstract available
    
    
    March 2020
18. YOO S, Oh S, Suh J, Park J, et al
    Optimal high-density lipoprotein cholesterol level for decreasing benign prostatic hyperplasia in men not taking statin medication: A historical cohort study.
    Prostate. 2020 Mar 20. doi: 10.1002/pros.23970.
    PubMed     Abstract available
    
    
    February 2020
19. XIA BW, Zhao SC, Chen ZP, Chen C, et al
    The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Prostate. 2020 Feb 27. doi: 10.1002/pros.23962.
    PubMed     Abstract available
    
    
    
20. HUR MS, Lee HW, Yang HM, Kwon HJ, et al
    Longitudinal muscular column in the prostatic urethral wall: Its form, shape, and possible function based on mathematical simulation in ejaculation.
    Prostate. 2020 Feb 12. doi: 10.1002/pros.23961.
    PubMed     Abstract available
    
    
    January 2020
21. ROMAN K, Hall C, Schaeffer AJ, Thumbikat P, et al
    TRPV1 in experimental autoimmune prostatitis.
    Prostate. 2020;80:28-37.
    PubMed     Abstract available
    
    
    December 2019
22. ANDO K, Sakamoto S, Takeshita N, Fujimoto A, et al
    Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxel.
    Prostate. 2019 Dec 9. doi: 10.1002/pros.23938.
    PubMed     Abstract available
    
    
    October 2019
23. LANGSTON ME, Bhalla A, Alderete JF, Nevin RL, et al
    Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk.
    Prostate. 2019;79:1622-1628.
    PubMed     Abstract available
    
    
    September 2019
24. ZHANG LG, Chen J, Meng JL, Zhang Y, et al
    Effect of alcohol on chronic pelvic pain and prostatic inflammation in a mouse model of experimental autoimmune prostatitis.
    Prostate. 2019;79:1439-1449.
    PubMed     Abstract available
    
    
    
25. JEON SH, Zhu GQ, Kwon EB, Lee KW, et al
    Extracorporeal shock wave therapy decreases COX-2 by inhibiting TLR4-NFkappaB pathway in a prostatitis rat model.
    Prostate. 2019;79:1498-1504.
    PubMed     Abstract available
    
    
    August 2019
26. KAIPAINEN A, Zhang A, Gil da Costa RM, Lucas J, et al
    Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion.
    Prostate. 2019 Aug 2. doi: 10.1002/pros.23874.
    PubMed     Abstract available
    
    
    
27. LOLLI C, De Lisi D, Conteduca V, Gurioli G, et al
    Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide.
    Prostate. 2019;79:1211-1220.
    PubMed     Abstract available
    
    
    June 2019
28. LI F, Pascal LE, Stolz DB, Wang K, et al
    E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
    Prostate. 2019 Jun 18. doi: 10.1002/pros.23806.
    PubMed     Abstract available
    
    
    
29. MOUSSA AS, Ragheb AM, Abdelbary AM, Ibrahim RM, et al
    Outcome of Botulinum Toxin-A intraprostatic injection for benign prostatic hyperplasia induced lower urinary tract symptoms: A prospective multicenter study.
    Prostate. 2019 Jun 12. doi: 10.1002/pros.23805.
    PubMed     Abstract available
    
    
    
30. NI J, Mizoguchi S, Bernardi K, Suzuki T, et al
    Long-lasting bladder overactivity and bladder afferent hyperexcitability in rats with chemically-induced prostatic inflammation.
    Prostate. 2019;79:872-879.
    PubMed     Abstract available
    
    
    May 2019
31. HAGA N, Akaihata H, Hata J, Hiraki H, et al
    The association between local arteriosclerosis of the prostatic arteries and chronic inflammation in human benign prostatic enlargement.
    Prostate. 2019;79:574-582.
    PubMed     Abstract available
    
    
    April 2019
32. JIN S, Xiang P, Liu J, Yang Y, et al
    Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8 (+) T cells in benign prostatic hyperplasia.
    Prostate. 2019 Apr 8. doi: 10.1002/pros.23801.
    PubMed     Abstract available
    
    
    
33. FUJII S, Yamashita S, Hayashi N, Goto T, et al
    Phosphodiesterase type 5 inhibitor attenuates chronic ischemia-induced prostatic hyperplasia in a rat model.
    Prostate. 2019;79:536-543.
    PubMed     Abstract available
    
    
    
34. YAMAGUCHI H, Kurita M, Okamoto K, Kotera T, et al
    Voiding behavior and chronic pelvic pain in two types of rat nonbacterial prostatitis models: Attenuation of chronic pelvic pain by repeated administration of tadalafil.
    Prostate. 2019;79:446-453.
    PubMed     Abstract available
    
    
    March 2019
35. JANG KS, Han IH, Lee SJ, Yoo J, et al
    Experimental rat prostatitis caused by Trichomonas vaginalis infection.
    Prostate. 2019;79:379-389.
    PubMed     Abstract available
    
    
    February 2019
36. MURPHY SF, Anker JF, Mazur DJ, Hall C, et al
    Role of gram-positive bacteria in chronic pelvic pain syndrome (CPPS).
    Prostate. 2019;79:160-167.
    PubMed     Abstract available
    
    
    November 2018
37. YUE L, Wang T, Ge Y, Ge M, et al
    Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.
    Prostate. 2018 Nov 18. doi: 10.1002/pros.23737.
    PubMed     Abstract available
    
    
    August 2018
38. CHEN P, Xiao H, Huang W, Xu DQ, et al
    Testosterone regulates myosin II isoforms expression and functional activity in the rat prostate.
    Prostate. 2018 Aug 2. doi: 10.1002/pros.23702.
    PubMed     Abstract available
    
    
    April 2018
39. INAMURA S, Ito H, Shinagawa T, Tsutsumiuchi M, et al
    Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Prostate. 2018 Apr 2. doi: 10.1002/pros.23518.
    PubMed     Abstract available
    
    
    February 2018
40. YELLEPEDDI VK, Radhakrishnan J, Radhakrishnan R
    Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue.
    Prostate. 2018;78:80-85.
    PubMed     Abstract available
    
    
    November 2017
41. SHI YF, Yu DJ, Jiang CY, Wang XJ, et al
    TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
    Prostate. 2017 Nov 23. doi: 10.1002/pros.23456.
    PubMed     Abstract available
    
    
    
42. SHIH HJ, Huang CJ, Lin JA, Kao MC, et al
    Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
    Prostate. 2017 Nov 9. doi: 10.1002/pros.23451.
    PubMed     Abstract available
    
    
    
43. DAVIDSSON S, Andren O, Ohlson AL, Carlsson J, et al
    FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer.
    Prostate. 2017 Nov 6. doi: 10.1002/pros.23442.
    PubMed     Abstract available
    
    
    
44. NEUZILLET Y, Raynaud JP, Radulescu C, Fiet J, et al
    Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
    Prostate. 2017;77:1512-1519.
    PubMed     Abstract available
    
    
    July 2017
45. COLINOT DL, Garbuz T, Bosland MC, Wang L, et al
    The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.
    Prostate. 2017;77:1066-1075.
    PubMed     Abstract available
    
    
    June 2017
46. NA R, Helfand BT, Chen H, Conran CA, et al
    A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
    Prostate. 2017 Jun 28. doi: 10.1002/pros.23380.
    PubMed     Abstract available
    
    
    
47. PEJCIC T, Tosti T, Tesic Z, Milkovic B, et al
    Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Prostate. 2017 Jun 8. doi: 10.1002/pros.23365.
    PubMed     Abstract available
    
    
    
48. NYGARD LH, Talala K, Taari K, Tammela TLJ, et al
    The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
    Prostate. 2017;77:1029-1035.
    PubMed     Abstract available
    
    
    May 2017
49. MIZOGUCHI S, Mori K, Wang Z, Liu T, et al
    Effects of Estrogen Receptor beta Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.
    Prostate. 2017;77:803-811.
    PubMed     Abstract available
    
    
    
50. HENNENBERG M, Acevedo A, Wiemer N, Kan A, et al
    Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace alpha1 -Adrenergic Tension in the Human Prostate.
    Prostate. 2017;77:697-707.
    PubMed     Abstract available
    
    
    
51. SHIBATA Y, Arai S, Miyazawa Y, Shuto T, et al
    Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content.
    Prostate. 2017;77:672-680.
    PubMed     Abstract available
    
    
    
52. HENRY G, Malewska A, Mauck R, Gahan J, et al
    Molecular pathogenesis of human prostate basal cell hyperplasia.
    Prostate. 2017;77:1344-1355.
    PubMed     Abstract available
    
    
    
53. MILBRANDT M, Winter AC, Nevin RL, Pakpahan R, et al
    Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.
    Prostate. 2017;77:1325-1334.
    PubMed     Abstract available
    
    
    April 2017
54. GONCALVES BF, de Campos SG, Goes RM, Scarano WR, et al
    Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironment.
    Prostate. 2017 Apr 12. doi: 10.1002/pros.23353.
    PubMed     Abstract available
    
    
    
55. SANCHEZ LR, Breser ML, Godoy GJ, Salazar FC, et al
    Chronic Infection of the Prostate by Chlamydia muridarum Is Accompanied by Local Inflammation and Pelvic Pain Development.
    Prostate. 2017;77:517-529.
    PubMed     Abstract available
    
    
    February 2017
56. INAMURA S, Shinagawa T, Hoshino H, Sakai Y, et al
    Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Prostate. 2017 Feb 9. doi: 10.1002/pros.23319.
    PubMed     Abstract available
    
    
    
57. FUNAHASHI Y, Majima T, Matsukawa Y, Yamamoto T, et al
    Intraprostatic Reflux of Urine Induces Inflammation in a Rat.
    Prostate. 2017;77:164-172.
    PubMed     Abstract available
    
    
    January 2017
58. BRESER ML, Motrich RD, Sanchez LR, Rivero VE, et al
    Chronic Pelvic Pain Development and Prostate Inflammation in Strains of Mice With Different Susceptibility to Experimental Autoimmune Prostatitis.
    Prostate. 2017;77:94-104.
    PubMed     Abstract available
    
    
    December 2016
59. KLAASSEN Z, Howard LE, Moreira DM, Andriole GL Jr, et al
    Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
    Prostate. 2016 Dec 19. doi: 10.1002/pros.23285.
    PubMed     Abstract available
    
    
    
60. ZHOU Y, Copeland B, Otto-Duessel M, He M, et al
    Low Testosterone Alters the Activity of Mouse Prostate Stem Cells.
    Prostate. 2016 Dec 14. doi: 10.1002/pros.23290.
    PubMed     Abstract available
    
    
    November 2016
61. WALLUKAT G, Jandrig B, Kunze R, Wendler JJ, et al
    Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.
    Prostate. 2016 Nov 24. doi: 10.1002/pros.23284.
    PubMed     Abstract available
    
    
    
62. REGIS L, Planas J, Carles J, Maldonado X, et al
    Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.
    Prostate. 2016 Nov 1. doi: 10.1002/pros.23256.
    PubMed     Abstract available
    
    
    October 2016
63. CAPOGROSSO P, Ventimiglia E, Moschini M, Boeri L, et al
    Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.
    Prostate. 2016 Oct 24. doi: 10.1002/pros.23266.
    PubMed     Abstract available
    
    
    July 2016
64. GU NY, Kim JH, Han IH, Im SJ, et al
    Trichomonas vaginalis induces IL-1beta production in a human prostate epithelial cell line by activating the NLRP3 inflammasome via reactive oxygen species and potassium ion efflux.
    Prostate. 2016;76:885-96.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Andrology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: